| Primary |
| Systemic Lupus Erythematosus |
14.8% |
| Rheumatoid Arthritis |
13.3% |
| Malaria Prophylaxis |
10.4% |
| Cutaneous Lupus Erythematosus |
8.9% |
| Malaria |
7.4% |
| Prophylaxis |
5.2% |
| Sarcoidosis |
4.4% |
| Vomiting |
4.4% |
| Poisoning Deliberate |
3.7% |
| Suicide Attempt |
3.7% |
| Congenital Infection |
3.0% |
| Mixed Connective Tissue Disease |
3.0% |
| Product Used For Unknown Indication |
3.0% |
| Sepsis |
3.0% |
| Sjogren's Syndrome |
3.0% |
| Nausea |
2.2% |
| Osteoporosis |
2.2% |
| Accidental Overdose |
1.5% |
| Cardiac Failure Congestive |
1.5% |
| Depression |
1.5% |
|
| Vomiting |
11.1% |
| Intentional Overdose |
9.3% |
| Ventricular Hypertrophy |
9.3% |
| Rash |
7.4% |
| Ventricular Fibrillation |
7.4% |
| Visual Field Defect |
7.4% |
| Atrioventricular Block Complete |
5.6% |
| Cardiac Arrest |
5.6% |
| Restlessness |
5.6% |
| Cardiotoxicity |
3.7% |
| Convulsion |
3.7% |
| Hypochromic Anaemia |
3.7% |
| Psychotic Disorder |
3.7% |
| Small Cell Lung Cancer Stage Unspecified |
3.7% |
| Vision Blurred |
3.7% |
| Abnormal Dreams |
1.9% |
| Acute Hepatic Failure |
1.9% |
| Alopecia |
1.9% |
| Anaemia |
1.9% |
| Atrioventricular Block |
1.9% |
|
| Secondary |
| Rheumatoid Arthritis |
18.8% |
| Intentional Overdose |
16.9% |
| Cutaneous Lupus Erythematosus |
12.4% |
| Product Used For Unknown Indication |
9.0% |
| Systemic Lupus Erythematosus |
6.8% |
| Suicide Attempt |
5.3% |
| Prophylaxis |
4.1% |
| Immunosuppression |
3.8% |
| Vomiting |
3.0% |
| Palpitations |
2.6% |
| Asthma |
2.3% |
| Drug Use For Unknown Indication |
2.3% |
| Malaria |
2.3% |
| Sjogren's Syndrome |
1.9% |
| Accidental Overdose |
1.5% |
| Lichen Planus |
1.5% |
| Plasmodium Vivax Infection |
1.5% |
| Pyrexia |
1.5% |
| Sarcoidosis |
1.5% |
| Arthritis |
1.1% |
|
| Visual Field Defect |
19.0% |
| Hypochromic Anaemia |
6.3% |
| Restlessness |
6.3% |
| Underdose |
6.3% |
| Ventricular Fibrillation |
6.3% |
| Completed Suicide |
4.8% |
| Drug Exposure During Pregnancy |
4.8% |
| Small Cell Lung Cancer Stage Unspecified |
4.8% |
| Vomiting |
4.8% |
| Weight Decreased |
4.8% |
| Blood Pressure Decreased |
3.2% |
| Brain Death |
3.2% |
| Cardiotoxicity |
3.2% |
| Diarrhoea |
3.2% |
| Haemoglobinuria |
3.2% |
| Intentional Overdose |
3.2% |
| Metastases To Lymph Nodes |
3.2% |
| Nervous System Disorder |
3.2% |
| Rheumatoid Arthritis |
3.2% |
| Somnolence |
3.2% |
|
| Concomitant |
| Rheumatoid Arthritis |
34.4% |
| Drug Use For Unknown Indication |
24.2% |
| Product Used For Unknown Indication |
13.7% |
| Hypertension |
5.0% |
| Pain |
4.4% |
| Systemic Lupus Erythematosus |
3.6% |
| Prophylaxis |
1.6% |
| Juvenile Arthritis |
1.5% |
| Anxiety |
1.3% |
| Depression |
1.3% |
| Hepatitis C |
1.3% |
| Cardiac Disorder |
1.2% |
| Gastric Disorder |
1.2% |
| Contraception |
0.9% |
| Hypothyroidism |
0.8% |
| Malaria Prophylaxis |
0.8% |
| Osteoporosis |
0.8% |
| Gastritis |
0.7% |
| Medical Diet |
0.6% |
| Blood Pressure |
0.6% |
|
| Vomiting |
9.8% |
| Weight Decreased |
9.8% |
| Pyrexia |
8.3% |
| Pneumonia |
7.5% |
| Weight Increased |
7.5% |
| Varicose Vein |
6.8% |
| Tuberculosis |
6.0% |
| Pain In Extremity |
5.3% |
| Lung Neoplasm |
4.5% |
| Pain |
4.5% |
| Drug Ineffective |
3.0% |
| Leukocytosis |
3.0% |
| Periarthritis |
3.0% |
| Renal Disorder |
3.0% |
| Spinal Disorder |
3.0% |
| Synovial Cyst |
3.0% |
| Trigeminal Nerve Disorder |
3.0% |
| Urticaria |
3.0% |
| Vaginal Haemorrhage |
3.0% |
| Vasculitis |
3.0% |
|
| Interacting |
| Rheumatoid Arthritis |
100.0% |
|
|
